Track JB Chemicals & Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for JB Chemicals & Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Quarterly breakdown of JB Chemicals & Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in JB Chemicals & Pharmaceuticals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of JB Chemicals & Pharmaceuticals Ltd.?
The current share price of JB Chemicals & Pharmaceuticals Ltd. is ₹ 2,410.57 as of 17 Jul 2026.
What is the market capitalisation of JB Chemicals & Pharmaceuticals Ltd.?
The market capitalisation of JB Chemicals & Pharmaceuticals Ltd. stands at ₹ 38,703.90 Cr.
What is the PE ratio of JB Chemicals & Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of JB Chemicals & Pharmaceuticals Ltd. is 54.55 as of the latest trailing twelve months data.
What is the ROE and ROCE of JB Chemicals & Pharmaceuticals Ltd.?
JB Chemicals & Pharmaceuticals Ltd. has a Return on Equity (ROE) of 18.69% and a Return on Capital Employed (ROCE) of 24.22% as per the latest financial reports.
What is the 52-week high and low of JB Chemicals & Pharmaceuticals Ltd.?
The 52-week high of JB Chemicals & Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of JB Chemicals & Pharmaceuticals Ltd.?
The dividend yield of JB Chemicals & Pharmaceuticals Ltd. is 0.82% based on the current market price.
What is the FII and DII holding in JB Chemicals & Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of JB Chemicals & Pharmaceuticals Ltd. shares.
What sector does JB Chemicals & Pharmaceuticals Ltd. belong to?
JB Chemicals & Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of JB Chemicals & Pharmaceuticals Ltd.?
The beta of JB Chemicals & Pharmaceuticals Ltd. is 0.32, indicating its price volatility relative to the broader market. Over the past 1 year, JB Chemicals & Pharmaceuticals Ltd. has delivered an absolute return of 47.65%.
What is the RSI of JB Chemicals & Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of JB Chemicals & Pharmaceuticals Ltd. is 61.19, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Stock Analysis
Fundamental analysis overview of JB Chemicals & Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Analysts have been raising forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has increased by 0.1% in the last 3 months, indicating earnings momentum
What is Earnings upgrade (3M)?
Consistently pays dividend
The company has not missed dividend payments once in the last 10 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 54.55 indicates that the stock is expensive on a standalone basis and is at a 88.3% premium to industry median P/E
What is P/E Ratio?
Median: 28.97
Value 54.55
-0.8680.32
Low dividend yield
The company has a low dividend yield of 0.82%
What is Dividend yield?
Neutral
Not enough talking points with neutral stance
No red flags found!
No significant red flags found in the stock.
Company Profile
Overview of JB Chemicals & Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). T...
Key personnel
Mr. Kaushal Singh Solanki
Chief Financial Officer
Mr. Sandeep Anil Phadnis
Company Secretary, Compliance Officer, Vice President - Secretarial